OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anticancer Mechanism of Curcumin on Human Glioblastoma
Shu Chyi Wong, Muhamad Noor Alfarizal Kamarudin, Rakesh Naidu
Nutrients (2021) Vol. 13, Iss. 3, pp. 950-950
Open Access | Times Cited: 79
Shu Chyi Wong, Muhamad Noor Alfarizal Kamarudin, Rakesh Naidu
Nutrients (2021) Vol. 13, Iss. 3, pp. 950-950
Open Access | Times Cited: 79
Showing 51-75 of 79 citing articles:
Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration
Sarmistha Mitra, Raju Dash, Yeasmin Akter Munni, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1153-1153
Open Access | Times Cited: 5
Sarmistha Mitra, Raju Dash, Yeasmin Akter Munni, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1153-1153
Open Access | Times Cited: 5
The evaluation of chitosan hydrogel based curcumin effect on DNMT1, DNMT3A, DNMT3B, MEG3, HOTAIR gene expression in glioblastoma cell line
Sanaz Abolfathi, Maryam Zare
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5977-5989
Closed Access | Times Cited: 2
Sanaz Abolfathi, Maryam Zare
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5977-5989
Closed Access | Times Cited: 2
Curcuminoids as Cell Signaling Pathway Modulators: A Potential Strategy for Cancer Prevention
Aneeza Noor, Saimeena Shafi, Nouroz Sehar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 21, pp. 3093-3117
Closed Access | Times Cited: 2
Aneeza Noor, Saimeena Shafi, Nouroz Sehar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 21, pp. 3093-3117
Closed Access | Times Cited: 2
Exploring the Prospective of Curcumin-loaded Nanomedicine in Brain Cancer Therapy: An Overview of Recent Updates and Patented Nanoformulations
Ravinder Verma, Lakshita Rao, Diksha Nagpal, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 3, pp. 278-294
Closed Access | Times Cited: 2
Ravinder Verma, Lakshita Rao, Diksha Nagpal, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 3, pp. 278-294
Closed Access | Times Cited: 2
Role of Scaffold Proteins in the Heterogeneity of Glioblastoma
Varun J. Iyer, John P. Donahue, Mahasin A. Osman
Research Square (Research Square) (2024)
Open Access
Varun J. Iyer, John P. Donahue, Mahasin A. Osman
Research Square (Research Square) (2024)
Open Access
Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?
Shadiya Fawzul Ameer, Mahmoud H. A. Mohamed, Qubaa Ahmed Elzubair, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Shadiya Fawzul Ameer, Mahmoud H. A. Mohamed, Qubaa Ahmed Elzubair, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Enhanced Combinatorial Effect of Resveratrol in Conjunction with other Naturally Occurring Bioactive Compounds
Stefan Profft, Vineet Chanduri, Elisabeth Sophie Bech, et al.
Research Square (Research Square) (2024)
Open Access
Stefan Profft, Vineet Chanduri, Elisabeth Sophie Bech, et al.
Research Square (Research Square) (2024)
Open Access
pH-Sensitive Zinc Oxide Nanoparticle-Controlled Sodium Alginate/Silica Hydrogel Beads: for Controlled Curcumin Release
Xueze Zhang, Yu Xiao, Shuqi Guo, et al.
Journal of Molecular Structure (2024), pp. 140967-140967
Closed Access
Xueze Zhang, Yu Xiao, Shuqi Guo, et al.
Journal of Molecular Structure (2024), pp. 140967-140967
Closed Access
Effect of curcumin on methotrexate-induced ovarian damage and follicle reserve in rats: the role of PARP-1 and P53
Mete Keçeci, Nesibe Karaoluk
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access
Mete Keçeci, Nesibe Karaoluk
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access
Phytochemical strategies in glioblastoma therapy: Mechanisms, efficacy, and future perspectives
Deepanjali Baliyan, Rajni Sharma, Shipra Goyal, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167647-167647
Closed Access
Deepanjali Baliyan, Rajni Sharma, Shipra Goyal, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167647-167647
Closed Access
Thymoquinone: A novel treatment option for triple negative breast cancer
Vani Mamillapalli, Vinuthna Rallapalli, Z M A Mohammed, et al.
Biomedicine (2024) Vol. 44, Iss. 1, pp. 13-20
Open Access
Vani Mamillapalli, Vinuthna Rallapalli, Z M A Mohammed, et al.
Biomedicine (2024) Vol. 44, Iss. 1, pp. 13-20
Open Access
Indian Ayurvedic medicine: Overview and application to brain cancer
Herbert B. Newton
Journal of Ayurveda and Integrative Medicine (2024) Vol. 15, Iss. 4, pp. 101013-101013
Open Access
Herbert B. Newton
Journal of Ayurveda and Integrative Medicine (2024) Vol. 15, Iss. 4, pp. 101013-101013
Open Access
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment
Pierre Bischoff, Jolie Bou-Gharios, G. Noël, et al.
Cancer/Radiothérapie (2024)
Open Access
Pierre Bischoff, Jolie Bou-Gharios, G. Noël, et al.
Cancer/Radiothérapie (2024)
Open Access
Construction and validation of cell cycle-related prognostic genetic model for glioblastoma
Runpeng Zhou, Kai Zhang, Tingting Dai, et al.
Medicine (2024) Vol. 103, Iss. 40, pp. e39205-e39205
Open Access
Runpeng Zhou, Kai Zhang, Tingting Dai, et al.
Medicine (2024) Vol. 103, Iss. 40, pp. e39205-e39205
Open Access
Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management
Saikat Dewanjee, Hiranmoy Bhattacharya, Chiranjib Bhattacharyya, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Saikat Dewanjee, Hiranmoy Bhattacharya, Chiranjib Bhattacharyya, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Curcumin and Its Potential to Target the Glycolytic Behavior of Lactate-Acclimated Prostate Carcinoma Cells with Docetaxel
Dongsic Choi, Jung‐Min Lee, Su-Hak Heo, et al.
Nutrients (2024) Vol. 16, Iss. 24, pp. 4338-4338
Open Access
Dongsic Choi, Jung‐Min Lee, Su-Hak Heo, et al.
Nutrients (2024) Vol. 16, Iss. 24, pp. 4338-4338
Open Access
Advances in nano-delivery of phytochemicals for glioblastoma treatment
Melvin A. Ambele, Botle Precious Damane, Thanyani Victor Mulaudzi, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access
Melvin A. Ambele, Botle Precious Damane, Thanyani Victor Mulaudzi, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access
Nose-to-brain delivery of self-assembled curcumin-nanocochleates for glioblastoma treatment
Deepak B. Bari, Suchita R. Helaskar, Manish B. Gagrani, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106557-106557
Closed Access
Deepak B. Bari, Suchita R. Helaskar, Manish B. Gagrani, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106557-106557
Closed Access
Natural Compounds in Glioma Therapy
Vasiliki Zoi, Maria Giannakopoulou, George Α. Alexiou, et al.
Interdisciplinary cancer research (2023)
Closed Access | Times Cited: 1
Vasiliki Zoi, Maria Giannakopoulou, George Α. Alexiou, et al.
Interdisciplinary cancer research (2023)
Closed Access | Times Cited: 1
Curcumin regulates cell proliferation and invasion of human triple-negative breast cancer Hs578T cells via the mTOR signaling pathway
Ze Chen, MengHan Li, Qing Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Ze Chen, MengHan Li, Qing Zhang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Anticancer Potential of Novel Cinnamoyl Derivatives against U87MG and SHSY-5Y Cell Lines
Niki Gouleni, Annalisa Di Rienzo, Sena Öner, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 39-49
Closed Access | Times Cited: 1
Niki Gouleni, Annalisa Di Rienzo, Sena Öner, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 39-49
Closed Access | Times Cited: 1
Nature-Derived Compounds as Potential Bioactive Leads against CDK9-Induced Cancer: Computational and Network Pharmacology Approaches
Abu Saim Mohammad Saikat, Khattab Al-Khafaji, Hafeza Akter, et al.
Processes (2022) Vol. 10, Iss. 12, pp. 2512-2512
Open Access | Times Cited: 2
Abu Saim Mohammad Saikat, Khattab Al-Khafaji, Hafeza Akter, et al.
Processes (2022) Vol. 10, Iss. 12, pp. 2512-2512
Open Access | Times Cited: 2
Paclitaxel and Curcumin as Dual-Drug-Loaded Lipid Nanocapsules in the Management of Brain Tumour
Mahfoozur Rahman, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.
Journal of Cluster Science (2022) Vol. 34, Iss. 4, pp. 1927-1938
Closed Access | Times Cited: 1
Mahfoozur Rahman, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.
Journal of Cluster Science (2022) Vol. 34, Iss. 4, pp. 1927-1938
Closed Access | Times Cited: 1
Root Vegetables: Biology, Nutritional Value and Health Implications
Mirela Ahmadi, Ștefan A. Hulea, Ioan Peț
IntechOpen eBooks (2022)
Open Access | Times Cited: 1
Mirela Ahmadi, Ștefan A. Hulea, Ioan Peț
IntechOpen eBooks (2022)
Open Access | Times Cited: 1
İZOİMPERATORİN ARACILIKLI ANTİKANSER AKTİVİTE: MİTOKONDRİYAL DİSFONKSİYONUN HEPG2 HÜCRELERİNDEKİ ROLÜ
Ali Ergüç, Ege Arzuk, Gökay Albayrak, et al.
Ankara Universitesi Eczacilik Fakultesi Dergisi (2023) Vol. 47, Iss. 3, pp. 13-13
Open Access
Ali Ergüç, Ege Arzuk, Gökay Albayrak, et al.
Ankara Universitesi Eczacilik Fakultesi Dergisi (2023) Vol. 47, Iss. 3, pp. 13-13
Open Access
